Details for: CL0000030

Cell ID: CL0000030

Cell Name: glioblast

Description: A non-terminally differentiated cell that develops form the neuroectoderm. Glioblast has the potential to differentiate into various types of glial cells, including astrocytes and oligodendrocytes.

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for glioblast within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for glioblast. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for glioblast. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for glioblast. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  glioblast (CL0000030)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary A [glioblast](/details-cell/CL0000030) is a non-terminally differentiated cell originating from the neuroectoderm, possessing the potential to develop into various glial cell lineages. Based on its gene significance profile, this cell type is characterized by an exceptionally high level of activity in fundamental biological processes. The top markers, identified by their unique expression levels (**Overall** context), include genes central to RNA and DNA processing ([HNRNPA2B1](/details-gene/3181), [HMGB1](/details-gene/3146)), energy metabolism ([GAPDH](/details-gene/2597), [COX1](/details-gene/4512)), and protein synthesis. This signature is consistent with a highly proliferative and metabolically demanding cell state, reflecting its role as a precursor and its frequent association with neoplastic conditions such as glioblastoma. ## Key Characteristics and Function The functional identity of the [glioblast](/details-cell/CL0000030) appears to be defined by the coordinated up-regulation of several core cellular machineries. The most significant markers can be grouped into distinct but interconnected functional clusters. * **Transcriptional and Post-Transcriptional Regulation:** A dominant feature of this cell is its intensive engagement in gene expression regulation. This is highlighted by the top two markers, [HNRNPA2B1](/details-gene/3181) (CSI: 66.46) and [HMGB1](/details-gene/3146) (CSI: 66.30), which are involved in mRNA splicing and chromatin structuring, respectively ([Link](https://doi.org/10.1073/pnas.86.24.9788), [Link](https://doi.org/10.1006/geno.1996.0369)). This is further supported by the high significance of [YBX1](/details-gene/4904), a key transcriptional regulator, the general transcription factor [BTF3](/details-gene/689), the nucleolar protein [NPM1](/details-gene/4869) involved in ribosome biogenesis, and the histone variant [H2AZ1](/details-gene/3015). This collection of markers suggests that the cell's phenotype is maintained by a robust and active system of controlling gene output from chromatin organization through to final mRNA processing. * **High Metabolic Output:** The [glioblast](/details-cell/CL0000030) exhibits a strong metabolic signature. The glycolytic enzyme [GAPDH](/details-gene/2597) (CSI: 62.69) is a highly specific marker, indicating a profound reliance on glycolysis. Concurrently, multiple components of the mitochondrial electron transport chain, such as [COX1](/details-gene/4512), [ND4](/details-gene/4538), and [ATP5MC2](/details-gene/517), are also exceptionally significant. This dual signature suggests a state of high energy demand being met by both glycolysis and oxidative phosphorylation, a hallmark of rapidly dividing cells. * **Protein Synthesis and Cytoskeletal Dynamics:** The cellular machinery for protein production and management is prominent. Markers like [SRP14](/details-gene/6727) (signal recognition particle for protein targeting) and [EEF1D](/details-gene/1936) (translation elongation factor) underscore a high rate of protein synthesis. Furthermore, the significance of genes involved in cytoskeletal organization, such as [CFL1](/details-gene/1072) (cofilin) and [MYL6](/details-gene/4637) (myosin light chain), suggests a structurally dynamic cell, likely related to cell division and motility. The cyclin [CCNI](/details-gene/10983) further reinforces its proliferative nature. * **Anti-Markers:** The least significant genes provide clues about pathways that are not defining for this cell type. The negative CSI scores for calcium-binding proteins like [S100A6](/details-gene/6277) and calmodulin genes ([CALM1](/details-gene/801), [CALM2](/details-cell/CL0000030)) may suggest that specific calcium-dependent signaling cascades are not primary drivers of the glioblast state. Similarly, the lack of prominence for markers of terminally differentiated cells underscores its undifferentiated nature. ## Clinical Significance and Contextual Roles Although the analysis is performed in an **Overall** context, the cellular name and gene signature strongly point toward a role in neuropathology, specifically glioblastoma, the most common and aggressive primary brain tumor. The observed characteristics—uncontrolled proliferation, high metabolic rate, and plasticity—are hallmarks of cancer. Several top markers have direct relevance to oncology. [HMGB1](/details-gene/3146) can be released from cells and act as a damage-associated molecular pattern (DAMP), promoting inflammation and tumor progression. Its expression has been noted in various adenocarcinomas ([Link](https://doi.org/10.1002/(sici)1097-0215(19970220)74:1<1::aid-ijc1>3.0.co;2-6)). [YBX1](/details-gene/4904) is a known oncoprotein that regulates the expression of numerous cancer-related genes. The high significance of [GSTP1](/details-gene/2950), a glutathione S-transferase involved in detoxification, may indicate an intrinsic mechanism for resistance to oxidative stress and chemotherapeutic agents. The entire gene expression profile paints a picture of a cell optimized for survival, proliferation, and adaptation, consistent with the aggressive clinical behavior of tumors derived from this lineage. ## Potential Mechanisms and Research Directions 1. **Hypothesis: Glioblasts possess a state of "metabolic hyper-activity" where both glycolysis and oxidative phosphorylation are uniquely and simultaneously elevated to a defining level, providing maximum bioenergetic and biosynthetic capacity for rapid proliferation.** * **Surprising Findings:** The designation of fundamental "housekeeping" genes like [GAPDH](/details-gene/2597) and multiple mitochondrial components (e.g., [COX1](/details-gene/4512)) as top *specificity* markers is notable. It suggests that the sheer magnitude of their expression in glioblasts is so extreme compared to other cell types that this metabolic state becomes a unique identifier, rather than just a baseline function. * **Testable Questions:** Can dual-targeting of glycolysis (e.g., via GLUT1 inhibitors) and mitochondrial respiration (e.g., via IACS-010759) induce synthetic lethality in glioblastoma models, and does the baseline expression level of these marker genes predict sensitivity to such therapies? 2. **Hypothesis: The glioblast's undifferentiated and proliferative state is maintained by a collective, high-level activity of a network of RNA/DNA-binding proteins, which function as a system to globally facilitate expression of proliferative genes while suppressing differentiation programs.** * **Surprising Findings:** The lack of a single dominant transcription factor and the instead high significance of a broad suite of proteins managing all stages of gene expression ([HNRNPA2B1](/details-gene/3181) for splicing, [HMGB1](/details-gene/3146) for chromatin, [YBX1](/details-gene/4904) for transcription, [NPM1](/details-gene/4869) for ribosome biogenesis) suggests a systems-level deregulation. The glioblast identity may not be driven by a single oncogenic switch but by the "hijacking" of the entire gene expression engine. * **Testable Questions:** Does the combined, partial inhibition of key nodes in this network (e.g., using small molecules against [HMGB1](/details-gene/3146) and antisense oligonucleotides against [HNRNPA2B1](/details-gene/3181)) lead to a collapse of the proliferative phenotype and potentially induce a forced differentiation state in glioblast organoids?